Target Discovery and Validation Reviews and Protocols Emerging Molecular Targets and Treatment Options,Volume 2 /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2007.
|
| Edición: | 1st ed. 2007. |
| Colección: | Methods in Molecular Biology,
361 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1385/1597452084 |
Tabla de Contenidos:
- Druggable Signaling Proteins
- DNA Methylation and Histone Modifications in Patients With Cancer
- Wnt Signaling as a Therapeutic Target for Cancer
- The NG2/HMP Proteoglycan as a Cancer Therapeutic Target
- Heterotrimeric G Proteins and Disease
- High-Mobility Group Box-1 Isoforms as Potential Therapeutic Targets in Sepsis
- Antisense Oligonucleotides
- Nucleic Acid-Based Aptamers as Promising Therapeutics in Neoplastic Diseases
- Guidelines for the Selection of Effective Short-Interfering RNA Sequences for Functional Genomics
- Suppression of Apoptosis in the Liver by Systemic and Local Delivery of Small-Interfering RNAs
- Target Validation Using RNA Interference in Solid Tumors
- Validation of Telomerase and Survivin as Anticancer Therapeutic Targets Using Ribozymes and Small-Interfering RNAs
- Collagen-Induced Arthritis in Mice
- Novel Opportunities for Therapeutic Targeting in Systemic Autoimmune Diseases
- Considerations for Target Validation and Industrial Approaches
- Regulatory RNAs
- Treatment Options and Individualized Medicine.